Enabling Oncology Site Success: Tackling the Barriers That Slow Cancer Research
Oncology clinical trials are becoming increasingly complex, placing new operational and administrative demands on both sponsors and research sites. Protocols
oncology
Enabling Oncology Site Success: Overcoming Administrative and Operational Barriers to Advance Cancer Research
In this webinar, leaders from cancer centers and biopharma companies will discuss the operational and institutional hurdles sites face and what can be done to address them. The panel will explore practical strategies to reduce burden, improve collaboration, and create a better experience for research staff and patients alike.
From Ethics to Evidence: Applying Real-World Data in Oncology Trials
Join experts from Johnson & Johnson Innovative Medicine, Bayer, The START Center for Cancer Care, and Advarra to discuss the ethical use of real-world data in clinical research.
Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential
Making Just-in-Time Oncology Trials Work: Overcoming Barriers and Unlocking Potential As part of Oncology Research Pulse, our new thought leadership
AACI/CCAF Annual Meeting
AACI/CCAF Annual Meeting Network with cancer center colleagues, groups, and health agencies to develop solutions to common challenges.
ASCO Annual Meeting
2025 ASCO Annual Meeting This conference will bring leading oncology professionals together to connect, inspire, and collaborate.
SCRS Oncology Site Solutions Summit
SCRS Oncology Site Solutions Summit Collaborate with research sites, sponsors, CROs, and solution at the SCRS Oncology Site Solutions Summit
4 Unique Challenges of Oncology Trials
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.
Unique Ethical Issues in Phase I Oncology Studies
Phase I oncology trials present distinct ethical challenges, such as participant vulnerability and the risk of therapeutic misconception, requiring careful oversight.
Enhancing Diversity, Equity, and Inclusion in Cancer Research: Overcoming Challenges in Clinical Trials
Diversity, equity, and inclusion (DEI) are critical pillars in the evolving landscape of cancer research. These values not only
Q&A – The New Urgency of Clinical Trials: How Oncology Leads the Evolution
In Advarra’s recent virtual symposium, experts from industry and academia met to discuss how oncology research has influenced agility in clinical trial design, particularly during the COVID-19 pandemic. Panelists talked about how the COVID-19 pandemic has impacted oncology research and propelled the field’s groundbreaking contributions to research. They also explored ways the pandemic response has shaped the future of oncology research—and research in general.
How Oncology Research Is Advancing Better Research
The COVID-19 pandemic has challenged every aspect of the clinical research industry. This new urgency has affirmed certain clinical trial innovations originally pioneered in the oncology space.